ESICM LIVES 2016: part three
J Serra(Great Ormond Street Hospital), T. Tamura(Elisabeth-TweeSteden Ziekenhuis), B. Encina(Texas Children's Hospital), I. Troncoso(Texas Children's Hospital), L. S. Shekerdemian(Vall d'Hebron Hospital Universitari), Nilüfer Ekşi Duran(Hospital Universitari Sagrat Cor), J. Caballero(Bristol Royal Hospital for Children), Javier Baena-(Texas Children's Hospital), Taylor Fontenot(Vall d'Hebron Hospital Universitari), Pau Micó Tormos(Texas Children's Hospital), A. Nishigaki(Elisabeth-TweeSteden Ziekenhuis), J. Bañeras(Texas Children's Hospital), A. Ruiz(University of Leeds), X. Nuvials, J. Lusk(Vall d'Hebron Hospital Universitari), Tomoaki Yatabe(Elisabeth-TweeSteden Ziekenhuis), Joan F. Andrés-Cordón(Bristol Royal Hospital for Children), M. YOKOYAMA(National Institute of Cardiovascular Diseases), Álex Sánchez‐Pla(Universitat de Barcelona), Juan Carlos Ruiz‐Rodríguez(National Institute of Cardiovascular Diseases), Peter Marshall(Edith Cowan University), T. Velasquez(Texas Children's Hospital), Koichi Yamashita, R. Belmonte(Texas Children's Hospital), Ursula G. Kyle(Vall d'Hebron Hospital Universitari)
Cited by 13
Related Papers
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
|Brain|2009|203
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
|Brain|2018|161
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
|Brain|2020|136
Evidence for mummification in Bronze Age Britain
|Antiquity|2005|114